Offer - Urjas Oil for just ₹ 1 X
Isonij, a prescription drug, is manufactured in various forms such as Tablet. Tuberculosis are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Isonij. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Isonij are Peripheral Neuropathy. While these are the most often observed Isonij side effects, there are can be others also. These have been listed below. These side effects of Isonij are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Isonij's effect is Moderate during pregnancy and Safe for lactating mothers. Further, the section on Isonij related warnings talks about Isonij's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Peripheral Neuropathy, Liver Disease, Jaundice must refrain from the use of Isonij since this can cause severe adverse effects. Other conditions have been mentioned below in the Isonij contraindications section.
Additionally, Isonij may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Isonij is safe while driving, and is is addictive in nature.
Isonij is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Isonij safe for pregnant women?
Pregnant women may experience moderate side effects from Isonij. It is best to stop taking Isonij immediately and inform your doctor if you notice any discomfort.
Is the use of Isonij safe during breastfeeding?
Isonij is safe for breastfeeding women.
What is the effect of Isonij on the Kidneys?
There may be some adverse effects on kidney after taking Isonij. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Isonij on the Liver?
Isonij can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Isonij on the Heart?
You can take Isonij without any fear of damage to the heart.
Isonij should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Isonij unless your doctor advises you to do so -
Is this Isonij habit forming or addictive?
No, you will not get addicted to Isonij.
Is it safe to drive or operate heavy machinery when consuming?
Isonij does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Isonij should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Isonij for mental disorders.
Interaction between Food and Isonij
Taking Isonij with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Isonij
Consuming Isonij with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716